Purpose: To map the cerebral metabolic rate of oxygen (CMRO 2 ) by estimating the oxygen extraction fraction (OEF) from gradient echo imaging (GRE) using phase and magnitude of the GRE data.
| I NT ROD UCTI ON
Cerebral metabolic rate of oxygen (CMRO 2 ) and oxygen extraction fraction (OEF) maps are valuable for evaluating neurologic disorders such as ischemic stroke.
1,2 Gradient echo (GRE) MR signal is highly sensitive to the strongly paramagnetic deoxyhemoglobin converted from weakly diamagnetic oxyhemoglobin. Several techniques have been proposed to estimate these maps based on quantitative modeling of either MRI magnitude or phase data. Magnitude modeling methods include quantitative imaging of extraction of oxygen and tissue consumption (QUIXOTIC), 3 calibrated fMRI, [4] [5] [6] [7] and quantitative BOLD (qBOLD). 8, 9 Phase modeling methods have been used for whole brain CMRO 2 measurements. 10, 11 Building on bles generation of CMRO 2 maps. 14, 15 The QSM-based CMRO 2 methods separate voxel-wise susceptibility into non-blood tissue susceptibility (v nb ) and blood susceptibility mainly driven by deoxyhemoglobin in the venous blood. The latter is then used to compute tissue oxygen consumption.
There are several challenges to the current CMRO 2 mapping methods. qBOLD approximates v nb from fully oxygenated blood, 9, 16 but it ignores tissue iron stored in ferritin or myelin that contributes to the rich v nb contrast in the brain. QSM-based methods assume a fixed and empirical linear relationship between the venous blood volume fraction (v) and cerebral blood flow (CBF) to obtain v, 17 but this relationship may vary with tissues and diseases. Although qBOLD estimates v directly from the data, it assumes that v nb is constant. On the contrary, QSM-based methods assume v from CBF, whereas v nb is estimated from the data. Because both methods use the same underlying gradient echo data, we propose to combine QSM and qBOLD (QSM1qBOLD) to map the OEF and CMRO 2 overcoming these assumptions.
| T HEOR Y
CMRO 2 (mmol/100 g/min) and OEF (%) can be expressed as
where CBF is the cerebral blood flow (mL/100 g/min), ½H a is the oxygenated heme molar concentration in the arteriole (7.377 lmol/mL) estimated from ½H a 5½H Á Y a , where ½H57:53 lmol/mL is the heme molar concentration in tissue blood assuming a hematocrit 
where g is the gyromagnetic ratio (267.513 MHz/T), B 0 is the main magnetic field (3T in our study), Hct is hematocrit (0.357), 18 Dv 0 is the susceptibility difference between fully oxygenated and fully deoxygenated red blood cells (4p 3 0.27ppm), 23 v ba is the susceptibility of fully oxygenated blood, 2108.3 ppb estimated with using Hct 0.357. 15 Note that the qBOLD assumption of neglecting susceptibility differences between non-blood tissue and fully oxygenated blood (v ba 5v nb ) 8, 16, 20, 24 is not made here. The second term in Eq. (3) contains the signal equation for the susceptibility of a voxel, F QSM , which is the sum of 3 terms: the non-blood tissue susceptibility, the plasma susceptibility, and the hemoglobin susceptibility: 15, 18 
where CBV is total blood volume (dimensionless fraction), w Hb the hemoglobin volume fraction (dimensionless) that was set to 0.0909 for tissue based on Hct 0.357, 18, [25] [26] [27] v p the blood plasma susceptibility, set to 237.7 ppb, 28 v oHb the oxyhemoglobin susceptibility (2813 ppb), 18, 26, 29 and ½dH v and ½dH a the concentration (mmol/mL) of deoxyhemoglobin in venules and arterioles, respectively. ½dH v and ½dH a will be expressed in terms of Y and Y a below. Finally, Dv Hb is the susceptibility difference between deoxy-and oxy-hemoglobin (12,522 ppb). 14, 28 Eq. (6) is then expressed in terms of (1) the ratio between the venous and total blood volume a5v=CBV, assumed to be constant (0.77), 30 (2) the fully oxygenated blood suscepti-
, and (4) the venous oxygenation,
. This results in:
where the 2 terms represent the contribution of blood and non-blood tissue to the total susceptibility, respectively. Note that v, which was estimated from CBF in QSM-based CMRO 2 mapping methods, 14, 15, 18 is now an unknown to be determined by data. This QSM1qBOLD model is compared with 2 previous methods: (1) a QSM method with minimum local variance (MLV) 18 ("QSM" hereafter), and (2) qBOLD that models the complex multi-echo gradient echo data as 20 ("qBOLD" hereafter):
| M ETH ODS

| Data acquisition
This study was approved by the local Institutional Review Board. Healthy volunteers were recruited (N 5 11; 10 males, 1 female, mean age 34 6 12 years) for brain MRI on a 3T scanner (HDxt, GE Healthcare) using an 8-channel brain receiver coil. After obtaining consent, all subjects were instructed to avoid caffeine or alcohol intake 24 h before the MRI.
MRI was performed in the resting state 15 
| Image processing
QSM reconstruction was performed as follows: first, an adaptive quadratic-fit of the GRE phase was used to estimate the total field. 34 Second, the projection onto dipole fields (PDF) method was used to obtain the local field. 35 Finally, the morphology enabled dipole inversion (MEDI) algorithm was used to compute susceptibility. 12, 13, 37 The susceptibility values were referenced to the susceptibility of cerebrospinal fluid (CSF) averaged over a manually drawn ROI on the first echo of the GRE acquisition. CBF maps (mL/100 g/min) were generated from the ASL data using the FuncTool software package (GE Healthcare, Waukesha, WI, USA). All images were co-registered and interpolated to the resolution of the QSM maps using the FSL FLIRT algorithm.
38,39
| Optimization
To improve convergence behavior during nonlinear fitting, the 5 unknowns v; Y; v nb ; S 0 ; R 2 were scaled to have approximately the same order of magnitude as the initial guess: x7 ! x jx 0 j , where x is the unknown in the original scale and x 0 is the corresponding initial guess. Initial guesses were obtained as follows: Y 0 was estimated from the straight sinus (SS) as the global constraint in previous QSM-based CMRO 2 and v nb;0 . The function G was calculated using the voxel spread function (VSF) method. 41 For some voxels, the initial guess for Y was not appropriate leading to an increase in signal as a function of TE after dividing out the F BOLD contribution. This then led to a negative R 2;0 . To avoid this situation, Y was gradually increased to insure a positive R 2;0 .
To speed up the F BOLD calculation, we used a Taylor expansion of the hypergeometric function ( 1 F 2 ) up to the 60 th order. 20 The lower and upper bounds were set to 0.5 and 2 for each scaled unknown, except for Y, which used the 0.1 and 0.9 bounds before scaling. At the start of each optimization, both the QSM and qBOLD terms in Eq. (3) were normalized by their respective values evaluated with the initial guess to compensate for the arbitrary scale of input MRI data. The tuning parameter w was selected using the L-curve method. 42 Corners of the L-curves for 2 randomly chosen subjects were both located at w5100 (Figure 1 ). The limited-memory Broyden-Fletcher-Goldfarb-Shanno-Bound algorithm was used for the constrained optimization. 43, 44 The optimization was stopped when the relative residual r i 5
, with E i as the energy of the ith iteration, was smaller than 0.005.
For "QSM," the optimization followed the previous QSMbased method using the MLV method and global CMRO 2 constraint. 18 For "qBOLD," the optimization was performed voxelwise, following Ref. 20 . The parameter scaling, initial guess, and boundary conditions were set in the same manner as for QSM1qBOLD. In addition, the initial frequency shift Df 0 was set to the total field value as obtained in the QSM process. 
| RES U LTS
The CMRO 2 in CGM were 140.4 6 14.9, 134.1 6 12.5, and 184.6 6 17.9 lmol/100 g/min (N 5 11) for the QSM, qBOLD, and QSM1qBOLD models, respectively. These corresponded to OEFs of 30.9 6 3.4%, 30.0 6 1.8%, and 40.9 6 2.2%, respectively (Supporting Information Table S1 ). In Figure 2 , compared to QSM and qBOLD, QSM1qBOLD showed higher CMRO 2 contrast between CGM and WM: 21.9 6 9.4 (P < 0.01), 36.0 6 6.4 (P < 0.01), and 54.6 6 10.3 lmol/100 g/min (N 5 11) for the QSM, qBOLD, and QSM1qBOLD models, respectively. QSM showed a smoother CMRO 2 map than QSM1qBOLD, except for a sharp transition at the GM/WM boundary.
In Figure 3 , QSM1qBOLD showed higher OEF than the 2 individual methods; the OEF values for whole brain were 34.5 6 3.1% (P < 0.01), 29.8 6 2.1% (P < 0.01), and 39.3 6 2.2% (N 5 11) for QSM, qBOLD, and QSM1qBOLD, respectively. QSM1qBOLD showed a relatively uniform OEF map as compared to QSM, and a less noisy OEF map than qBOLD. The OEF SDs in CGM were lower for QSM1qBOLD than for each individual method: 16.3 6 0.9% (P < 0.01), 19.4 6 1.5% (P < 0.01), and 12.3 6 1.2% (N 5 11) for QSM, qBOLD, and QSM1qBOLD, respectively. The venous blood volume v was slightly higher for QSM1qBOLD as compared to QSM and qBOLD: in CGM, the values were 4.3 6 0.4% (P < 0.01), 4.1 6 0.4% (P < 0.01), and 4.5 6 0.4%, and in WM, 3.5 6 0.3% (P 5 0.011), 3.2 6 0.3%
F IGUR E 1 L-curves in 2 randomly selected subjects to determine tuning parameter w. The L-curve corners were located at w 5 100 in both subjects. E qBOLD and E QSM indicate the energy terms in Eq. (3) (P < 0.01), and 3.5 6 0.3% for QSM, qBOLD, and QSM1qBOLD, respectively. v nb from QSM and QSM1qBOLD showed similar contrast at the CGM/WM boundary, it was higher in CGM than in nearby WM. Average v nb values were similar between QSM and QSM1qBOLD as compared to qBOLD (2108.3 ppb assumed for the whole brain): 212.3 6 3.7 ppb (p<0.01) and 219.8 6 3.5 ppb in CGM, and 215.3 6 3.9 ppb (P < 0.01) and 218.7 6 3.5 ppb in WM (N 5 11) for QSM and QSM1qBOLD, respectively. The v map of the QSM model and the v nb of the qBOLD model were not obtained through optimization, but given by a priori assumptions.
F IGUR E 2 CMRO 2 map in axial, sagittal, and coronal sections from a subject reconstructed using QSM, qBOLD, and QSM1qBOLD methods. The corresponding T 1 -weighted anatomical images are shown on the right. QSM1qBOLD shows higher GM/WM contrast than QSM or qBOLD F IGUR E 3 OEF, venous volume (v), non-blood tissue susceptibility (v nb ), and CMRO 2 maps in a second subject reconstructed using QSM, qBOLD, and QSM1qBOLD models. The OEF obtained using QSM1qBOLD is more uniform than that of QSM and is greater than that of qBOLD In Figure 4 , QSM1qBOLD showed higher CMRO 2 and OEF values than both QSM and qBOLD in all ACA, MCA, PCA, and WM ROIs (P < 0.01). All 3 methods showed lower CMRO 2 in WM than in ACA, MCA, and PCA (P < 0.01).
In the Bland-Altman plots ( Figure 5 ), the mean differences were 43.5 lmol/100 g/min (QSM vs. QSM1qBOLD) and 51.2 lmol/100 g/min (qBOLD vs. QSM1qBOLD) for CMRO 2 (P < 0.01), and 9.8% (QSM vs. QSM1qBOLD) and 10.9% (qBOLD vs. QSM1qBOLD) for OEF (P < 0.01).
| D IS C US S I ON
Our results demonstrate the feasibility of a QSM1qBOLD method for mapping CMRO 2 by comprehensive modeling of both the magnitude and phase of multi-echo gradient echo data. When either QSM modeling phase or qBOLD modeling magnitude are used individually to estimate CMRO 2 , a number of assumptions are required: a linear relationship between CBF and v and the minimum local variance of the estimated parameters within a tissue block for the QSM-based method, 18 and constant non-blood tissue susceptibility for the qBOLD method. 16, 20 These assumptions may cause errors and are eliminated in the proposed QSM1qBOLD method. Compared to QSM and qBOLD alone, the proposed QSM1qBOLD shows clearer GM/WM CMRO 2 contrasts (Figure 2 ), more uniform OEF compared to QSM (Figure 3) , and better agreement with results presented using other independent CMRO 2 estimation methods such as PET. 45 By overcoming the limited availability of PET, MRI provides greater accessibility for patient studies. Without any vascular challenge, QSM1qBOLD can be readily applied to study damage to vital organs caused by oxygen-deficiency, including
Alzheimer's disease, 46 ,47 multiple sclerosis, 48, 49 and ischemia in stroke. 1, 50 Compared to qBOLD, QSM1qBOLD shows higher OEF ( Figures 3, 4 and 5) , with 39.3 6 2.2% for the whole brain; this is in a good agreement with results from previous PET studies that have OEFs of 35 6 7%, 51 42.6 6 5.1%, 41 6 6%, 53 and 40 6 9%. 54 This difference is not driven by venous blood volume (v), which was found to be similar between qBOLD and QSM1qBOLD ( Figure 3) . Instead, the higher OEF may be explained by the inclusion of non-blood tissue susceptibility (v nb ) as a variable, which, in qBOLD, is assumed to be equal to the susceptibility of fully oxygenated blood (v ba ). The resulting v nb (219.8 6 3.5 ppb in CGM) is greater than v ba (2108.3 ppb). To obtain the same measured susceptibility difference dx in Eq. (5) when v ba 2v nb <0, the venous oxygenation Y needs to decrease, which leads to a higher OEF (Eqs. (2) and (5)). This suggests that inclusion of v nb was a factor in the observed OEF increase. QSM1qBOLD shows a higher OEF average than QSM for the whole brain (39.3 6 2.2% vs. 34.5 6 3.1%). A likely cause of this may lie in the use of the global constraint in QSM, 18 which is not used in QSM1qBOLD. The global constraint from straight sinus (SS) might not precisely estimate the average oxygenation in the whole brain because the SS may not represent all the draining veins 55, 56 which are known to have considerable variation (e.g. 47.7% $ 75.3%).
57
At the GM/WM boundary in the CMRO 2 map, the QSM method shows a sharp transition, whereas the QSM1qBOLD method reveals a gradual change (Figures 2 and 3) . The sharp GM/WM edge in QSM may be caused by separate optimization for the GM and WM; 18 in the QSM1qBOLD method, the optimization was performed for whole brain. The CMRO 2 GM/WM contrast in QSM1qBOLD is primarily driven by . In all ROIs, QSM1qBOLD provides higher CMRO 2 and OEF values than QSM or qBOLD (P < 0.01). *P < 0.01 (paired t-test). "n.s." indicates that the difference is not significant (P > 0.1)
CBF because the OEF map looks fairly uniform ( Figure 3) . A lack of CMRO 2 GM/WM contrast in QSM is not uniform and more prominent in areas where the OEF appears underestimated ( Figure 3 , top and bottom left). Errors in GM/WM segmentation or smoothing by the MLV assumption may have caused these local underestimations. The CMRO 2 and OEF maps are smoother using the QSM method (Figures 2 and 3 ). This may be caused by the use of MLV in the QSM method, 18 which assumes that CMRO 2 and v nb are constant within small blocks of brain tissue, to overcome the underdetermined system (2 unknowns and 1 equation per voxel) when no challenge is used. The MLV assumption in the QSM method is highly dependent on the block setting (e.g., block size and number of block shifts). The QSM1qBOLD model eliminates this MLV assumption using qBOLD modeling of the magnitude data.
The non-blood tissue susceptibility v nb shows a clear GM/WM contrast using QSM1qBOLD (Figure 3 ). This is consistent with the difference in myelin content between CGM and WM. 58 The QSM1qBOLD model may still be affected by residual limitations in the QSM and qBOLD models. The qBOLD term ignores the detailed microstructure of brain tissue, including myelin water components and magnetic anisotropy of myelin in white matter. qBOLD Eq. (4) may be expanded with 2 different R 2 s to account for myelin water, and fiber orientation-dependent effects in Eq. (5) to consider myelin magnetic anisotropy. The empirical L-curve analysis was used to determine relative weighting (w) in Eq. (3). Additional studies are needed to investigate the influence of the weighting w, measurement error, and differences in acquisition schemes. For instance, the propagation of bias and error in the estimated susceptibility into QSM1qBOLD measurements will depend on the choice of w. Spatial resolution will play a role in the choice of w: although smaller voxels typically improve QSM estimates, 59 the resulting SNR loss may affect qBOLD estimates negatively, because it requires high SNR. 16 Although QSM1qBOLD removed the linear CBF/CBV assumption in QSM and the constant non-blood tissue susceptibility assumption in qBOLD, it retains a constant ratio between venous and total blood volume (0.77), constant F IGUR E 5 Bland-Altman plots comparing OEF and CMRO 2 values in VT ROIs between QSM1qBOLD and the 2 reference methods, QSM and qBOLD. The mean differences are 43.5 lmol/100 g/min (QSM vs. QSM1qBOLD) and 51.2 lmol/100 g/min (qBOLD vs. QSM1qBOLD) for CMRO 2 (P < 0.01), and 9.8% (QSM vs. QSM1qBOLD) and 10.9% (qBOLD vs. QSM1qBOLD) for OEF (P < 0.01) tissue hematocrit (0.357), and constant oxygenated heme molar concentration in the arteriole (7.377 lmol/mL) for the whole brain, which may vary among subjects and diseases. The ASL-measured CBF is known to contain errors, particularly in WM 60 and may deteriorate with the use of shorter post-label delay in this study (1525 ms was used in the clinical protocol at our institution) than the recommended value of 2000 ms, 32 which will propagate to CMRO 2 . The OEF and v estimations in large veins might be errorous because they were treated in the same way as normal brain tissue. This error could be suppressed using the v51 prior for large veins. The QSM1qBOLD optimization (Eq. 3) is nonconvex, with convergence susceptible to dependency on solver implementation, initial guesses, parameter scaling, and stopping criterion. A reference standard such as 15 O PET is needed to validate CMRO 2 methods. Finally, the application of this method and its validation for a general patient population remains to be investigated.
| C ONCL US I ON
In conclusion, our study demonstrated the feasibility of a comprehensive quantitative CMRO 2 mapping method by combining QSM and qBOLD-based methods. In healthy subjects, the CMRO 2 map obtained with QSM1qBOLD shows better GM/WM contrast as compared to an individual QSM or qBOLD-based method, whereas the OEF map appeared more uniform compared to the QSM-based method.
